Physician profile
Michael Joseph Rinaldi
NPI 1891708939
$722,264.98
in general payments reported to CMS, 2019-2025
28 companies · $164K in 2025
The $164K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $47K · 2021: $67K · 2022: $99K · 2023: $114K · 2024: $174K · 2025: $164K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $245K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $122K · Travel and Lodging: $54K · Food and Beverage: $23K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,875 · Grant: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $244,918.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $122,387.50 |
| Travel and Lodging | $54,399.01 |
| Food and Beverage | $22,830.04 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,875.00 |
| Grant | $2,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $403,323.48 | 2019-2025 | Watchman Access System, Watchman Flx, Watchman |
| Abbott Laboratories | $224,938.36 | 2019-2025 | Mitraclip, Tendyne, Triclip |
| Edwards Lifesciences Corporation | $69,824.17 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Heartflow, INC. | $8,173.07 | 2022-2025 | Ffrct |
| Cardinal Health 200 LLC | $4,834.17 | 2019-2020 | |
| Shockwave Medical, INC | $3,750.00 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $1,453.03 | 2024 | Thermocool Sf |
| Medtronic, INC. | $1,205.92 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Ffrangio |
| Silk Road Medical, INC. | $750.00 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Medtronic Vascular, INC. | $639.14 | 2019 | |
| Philips North America LLC | $612.05 | 2023-2025 | Multi Modality Ivus Other Systems, (P79) Azurion 7 B20, (Br5) Peripheral Ivus |
| Inari Medical, INC. | $475.65 | 2019-2020 | |
| Abiomed | $453.88 | 2021-2024 | Impella |
| Verge Medical, INC. | $324.91 | 2024 | |
| Teleflex LLC | $319.21 | 2020-2023 | Guideliner, Twin-Pass |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $228.08 | 2023-2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $183.64 | 2019-2021 | |
| Stryker Corporation | $140.07 | 2025 | Flowtriever |
| Amgen INC. | $124.99 | 2020 | |
| Novo Nordisk INC | $120.79 | 2023 | |
| Janssen Pharmaceuticals, INC | $99.28 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.64 | 2023 | Lifevest |
| Angiodynamics, INC. | $68.00 | 2023 | Alphavac |
| Cordis US Corp. | $33.59 | 2023 | Rain Sheath Transradial |
| Siemens Medical Solutions USA, INC. | $29.65 | 2023 | Acuson Sequoia Diagnostic Ultrasound System |
| Cook Medical LLC | $27.04 | 2019 | |
| Cardiovascular Systems INC. | $22.93 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.24 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rinaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.